gynecologic

Zentalis Pharmaceuticals Presents Updated Clinical Data at the Society of Gynecologic Oncology 2025 Annual Meeting on Womens CancerZentalis Pharmaceuticals Presents Updated Clinical Data at the Society of Gynecologic Oncology 2025 Annual Meeting on Womens Cancer

Zentalis Pharmaceuticals Presents Updated Clinical Data at the Society of Gynecologic Oncology 2025 Annual Meeting on Womens Cancer

March 15, 2025 11:25 ET  | Source: ZENTALIS PHARMACEUTICALS Azenosertib median duration of response (mDOR) updated to 6.3 months in…

2 months ago